What's Going On With Safety Shot Inc Stock? (UPDATED)
Portfolio Pulse from Erica Kollmann
Safety Shot, Inc. (NASDAQ:SHOT) stock plummeted after Capybara Research released a short report accusing the company of fraud and predicting FDA intervention. The report follows Safety Shot's stock surge due to a west coast product launch. The stock fell nearly 16% to $4.06, with trading volume significantly exceeding the average.
November 22, 2023 | 4:07 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Safety Shot's stock dropped significantly after a negative short report by Capybara Research, which could lead to increased scrutiny and potential FDA intervention.
The short report from Capybara Research directly targets Safety Shot's credibility and predicts regulatory action, which has led to a sharp decline in stock price. Given the severity of the allegations and the high trading volume, the negative impact on the stock is likely to continue in the short term.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100